compared to its average ratio and a 36-month beta value of 0.45. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”

The average price point forecasted by analysts for Leap Therapeutics Inc (LPTX) is $13.70, which is $11.87 above the current market price. The public float for LPTX is 23.46M, and currently, short sellers hold a 3.17% ratio of that float. The average trading volume of LPTX on November 20, 2023 was 238.41K shares.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


LPTX) stock’s latest price update

Leap Therapeutics Inc (NASDAQ: LPTX)’s stock price has gone rise by 15.09 in comparison to its previous close of 1.59, however, the company has experienced a 32.61% increase in its stock price over the last five trading days. PRNewsWire reported 2023-09-05 that CAMBRIDGE, Mass., Sept. 5, 2023 /PRNewswire/ — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E.

LPTX’s Market Performance

Leap Therapeutics Inc (LPTX) has seen a 32.61% rise in stock performance for the week, with a 29.79% gain in the past month and a -16.82% plunge in the past quarter. The volatility ratio for the week is 14.61%, and the volatility levels for the past 30 days are at 11.73% for LPTX. The simple moving average for the past 20 days is 20.32% for LPTX’s stock, with a -48.73% simple moving average for the past 200 days.

Analysts’ Opinion of LPTX

Many brokerage firms have already submitted their reports for LPTX stocks, with Mizuho repeating the rating for LPTX by listing it as a “Buy.” The predicted price for LPTX in the upcoming period, according to Mizuho is $6 based on the research report published on October 04, 2021 of the previous year 2021.

LPTX Trading at 20.70% from the 50-Day Moving Average

After a stumble in the market that brought LPTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.06% of loss for the given period.

Volatility was left at 11.73%, however, over the last 30 days, the volatility rate increased by 14.61%, as shares surge +21.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.08% lower at present.

During the last 5 trading sessions, LPTX rose by +32.61%, which changed the moving average for the period of 200-days by -71.50% in comparison to the 20-day moving average, which settled at $1.5369. In addition, Leap Therapeutics Inc saw -59.33% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for LPTX

The total capital return value is set at -67.62, while invested capital returns managed to touch -65.36. Equity return is now at value -114.09, with -98.12 for asset returns.

Based on Leap Therapeutics Inc (LPTX), the company’s capital structure generated 1.15 points at debt to equity in total, while total debt to capital is 1.14. Total debt to assets is 0.96, with long-term debt to equity ratio resting at 0.45. Finally, the long-term debt to capital ratio is 0.44.

The liquidity ratio also appears to be rather interesting for investors as it stands at 6.05.


To put it simply, Leap Therapeutics Inc (LPTX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.